Iran's Pharmaceutical Sector Thrives Despite Sanctions, Exports to 50 Countries

Iran's pharmaceutical sector has defied international sanctions, with the country exporting medicinal and pharmaceutical products to approximately 50 countries worldwide.

Iran (IMNA) - According to the Iran Food and Drug Administration (IFDA), nearly 100 Iranian companies are exporting these products to various destinations.

The IFDA's secretary, Asef Mahdavi, announced on Sunday that Iranian companies have the capacity to produce medicines several times more than meeting domestic needs. The medicines developed in Iran are competitive with European products in terms of price and Indian products in terms of quality.

The export of medical equipment has also seen significant growth, with a 300 percent increase in the first four months of this year. The IFDA Head, Heidar Mohammadi, stated that Iran's pharmaceutical market is worth over 106 trillion toman (approximately $2 billion), with 99 percent of drugs used in the country being produced domestically.

Iran has made substantial progress in the medical sector despite illegal Western sanctions. The country has become self-reliant in producing medicines and health equipment, and has increased sales to many countries.

News ID 764166


Your Comment

You are replying to: .